In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression

References

• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol 2008;4:1119–1129.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Kuna P. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties]. Pol Merkur Lekarski 2002;12:248–252.
   PubMedGoogle Scholar
• Nemceková E, Nosálóvá G, Franová S. [Ambroxol and protective reflexes of the respiratory tract]. Bratisl Lek Listy 1998;99:111–115.
   PubMedGoogle Scholar
• Pfeifer S, Zissel G, Kienast K, Müller-Quernheim J. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. Eur J Med Res 1997;2:129–132.
   PubMedGoogle Scholar
• Guyatt GH, Townsend M, Kazim F, Newhouse MT. A controlled trial of ambroxol in chronic bronchitis. Chest 1987;92:618–620.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Halliday HL. Current perspectives on the drug treatment of neonatal respiratory distress syndrome. Paediatr Drugs 1999;1:19–30.
   PubMedGoogle Scholar
• Vergin H, Bishop-Freudling GB, Miczka M, Nitsche V, Strobel K, Matzkies F. [The pharmacokinetics and bioequivalence of various dosage forms of ambroxol]. Arzneimittelforschung 1985;35:1591–1595.
   PubMed Web of Science ®Google Scholar
• Alighieri T, Avanessian S, Berlini S, Bianchi SG, Deluigi P, Valducci R et al. Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies. Arzneimittelforschung 1988;38:92–94.
   PubMed Web of Science ®Google Scholar
• Kubo W, Miyazaki S, Dairaku M, Togashi M, Mikami R, Attwood D. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations. Int J Pharm 2004;271:233–240.
   PubMed Web of Science ®Google Scholar
• Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev 1999;99:3181–3198.
   PubMed Web of Science ®Google Scholar
• Lu Z, Chen W, Hamman JH. Chitosan-polycarbophil complexes in swellable matrix systems for controlled drug release. Curr Drug Deliv 2007;4:257–263.
   PubMedGoogle Scholar
• Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001;48:229–247.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Schwartz JB. Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev Ind Pharm 2003;29:131–138.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev 2001;48:137–138.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Thirawong N, Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm 2007;66:435–450.
   PubMed Web of Science ®Google Scholar
• Ranade VV, Hollinger MA. Oral drug delivery. In: Ranade VV, Hollinger MA, Cannon JB eds. Drug Delivery Systems. Boca Raton, FL: CRC Press, 2004:149–208.
   Google Scholar
• Miyajima M, Koshika A, Okada J, Kusai A, Ikeda M. Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix. J Control Release 1998;56:85–94.
   PubMed Web of Science ®Google Scholar
• Luner PE, Kirsch LE, Majuru S, Oh E, Joshi AB, Wurster DE et al. Preformulation studies on the S-isomer of oxybutynin hydrochloride, an Improved Chemical Entity (ICE). Drug Dev Ind Pharm 2001;27:321–329.
   PubMed Web of Science ®Google Scholar
• Velasco MV, Munoz-Ruiz A, Monedero MC, Jimenez-Castellanos MR. Flow studies on maltodextrins as directly compressible vehicles. Drug Dev Ind Pharm 1995;21:1235–1243
   Web of Science ®Google Scholar
• Carr RL, Classifying flow properties of solids. Chem Eng 1964;72:69–72
   Google Scholar
• Hausner HH. Friction condition in a mass of metal powders. Int J Powder Metall 1967;3:7–13.
   Google Scholar
• Li Wan Po A, Mroso PV. Drug-drug incompatibility in the solid state: kinetic interpretation, modelling and prediction. Inter J Pharm 1984;18:287–298.
   Google Scholar
• Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y et al. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int J Pharm 2005;304:91–101.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci 1983;72:1189–1191.
   PubMed Web of Science ®Google Scholar
• Signoretti EC, Sena CD, Dell’Utri A, Alimonti S. An investigation into eventual interactions between clenbuterol and some mucolytic drugs by differential scanning calorimetry. Drug Dev Ind Pharm 1988;14:1167–1184.
   Web of Science ®Google Scholar
• Staniforth J. Powder flow. In: Aulton M, ed. Pharmaceutics: the Science of Dosage Form Design. 2nd edition. Edinburgh, Churchill Livingstone: Longman group, 2002:198–210.
   Google Scholar
• Shangraw RF. Compressed tablets by direct compression. In: Lieberman HA, Lachman L, Shwartz JB, eds. Pharmaceutical Dosage Forms: Tablets.Vol 1, New York, NY: Marcel Dekker Inc., 1989:198–202.
   Google Scholar
• Chowhan ZT, Chow YP. Powder flow studies i. powder consolidation ratio and its relationship to capsule-filling—Weight Variation, Int J Pharm 1980; 4:317–326.
   Google Scholar
• Hiestand EN. Mechanical behavior of solids: elements of powder beds and compacts. In: Stowell JG, ed. Mechanics and Physical Principles for Powders and Compacts, 2nd ed. West Lafayette, IN, SSCI Inc., 2002:21–48.
   Google Scholar
• Amidon GE. Physical and mechanical property characterization of powders. In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids (Drugs and the Pharmaceutical Sciences). Vol. 70. New York, NY: Marcel Dekker Inc., 1995:281–319.
   Google Scholar
• Wells JI. Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances. West Sussex, England: Ellis Horwood Ltd., 1988:209–214.
   Google Scholar
• Li CL, Martini LG, Ford JL, Roberts M. The use of hypromellose in oral drug delivery. J Pharm Pharmacol 2005;57:533–546.
   PubMed Web of Science ®Google Scholar
• Ebba F, Piccerelle P, Prinderre P, Opota D, Joachim J. Stress relaxation studies of granules as a function of different lubricants. Eur J Pharm Biopharm 2001;52:211–220.
   PubMed Web of Science ®Google Scholar
• Sharma V, Philip AK, Pathak K. Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin. AAPS PharmSciTech 2008;9:87–94.
   PubMed Web of Science ®Google Scholar
• Sievert B, Siewert M. Dissolution test for extended release products. In: Dressman JB, Lennernäs H, ed. Oral Drug Absorption: Prediction and Assessment. New York, NY: Marcel Dekker; 2000: 183–195.
   Google Scholar
• Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur J Pharm Biopharm 2004;58:51–59.
   PubMed Web of Science ®Google Scholar
• Skoug JW, Mikelsons MV, Vigneron CN, Stemm NL. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. J Control Release 1993;27:227–245.
   Web of Science ®Google Scholar
• Khan GM, Jiabi Z. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. J Control Release 1998;54:185–190.
   PubMed Web of Science ®Google Scholar
• Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung KC. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J Pharm Sci 1996;85:732–740.
   PubMed Web of Science ®Google Scholar
• Ranga-Rao KV, Devi KP. Swelling controlled release systems: recent developments and applications. Int J Pharm 1988;48:1–16.
   Google Scholar
• Sriamornsak P, Sungthongjeen S. Modification of theophylline release with alginate gel formed in hard capsules. AAPS PharmSciTech 2007;8:E51.
   Web of Science ®Google Scholar
• Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm 1989;57:169–172.
   Web of Science ®Google Scholar
• Sasa B, Odon P, Stane S, Julijana K. Analysis of surface properties of cellulose ethers and drug release from their matrix tablets. Eur J Pharm Sci 2006;27:375–383.
   PubMed Web of Science ®Google Scholar
• Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad MR. The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. Farmaco 2004;59:819–825.
   PubMedGoogle Scholar
• Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release 1999;57:75–85.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12–17.
   PubMed Web of Science ®Google Scholar